NCT00644917View on ClinicalTrials.gov

Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment

PHASE1CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Healthy

Interventions

DRUG

Xenaderm

20mg under Finn chambers

DRUG

Placebo

20mg under Finn chambers

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Healthpoint

INDUSTRY